Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial

BACKGROUND: Recent evidence suggests that the lipid-lowering agent atorvastatin is also a potent immunomodulator. The aim of this study was to investigate the possible effect of atorvastatin on the decline of residual beta cell function in recent-onset type 1 diabetes. METHODS AND FINDINGS: The rand...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Martin, Stephan, Herder, Christian, Schloot, Nanette C., Koenig, Wolfgang, Heise, Tim, Heinemann, Lutz, Kolb, Hubert
Médium: Artigo
Jazyk:Inglês
Vydáno: Public Library of Science 2011
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3055882/
https://ncbi.nlm.nih.gov/pubmed/21412424
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0017554
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky